Showing results (81-90 of 762) with videos related to
Sort By:
Pageof 77
Acta Anaesthesiologica Scandinavica|January 1, 1977
Prostaglandin F2alpha as a mediator of pulmonary changes during platelet aggregationK Rådegran, P Olsson, B Alme, et al.Haemostasis|January 1, 1979
Serotonin uptake and release by platelets adhering to polyethyleneR Malmgren, R Larsson, P Olsson, et al.Thrombosis and Haemostasis|December 17, 1985
Uptake and inactivation of thrombin on rabbit aortic endothelium studied with two different substratesJ Swedenborg, M Dryjski, S Frebelius, et al.Journal of Biomedical Materials Research|May 1, 1995
Control of contact activation on end-point immobilized heparin: the role of antithrombin and the specific antithrombin-binding sequenceJ Sanchez, G Elgue, J Riesenfeld, et al.Scandinavian Journal of Clinical and Laboratory Investigation|October 1, 1981
Polarographic pO2 sensors with heparinized membranes for in vitro and continuous in vivo registrationE Nilsson, G Edwall, R Larsson, et al.Journal of Biomedical Materials Research|October 23, 1997
Inhibition of the plasma contact activation system of immobilized heparin: relation to surface density of functional antithrombin binding sitesJ Sánchez, G Elgue, J Riesenfeld, et al.Thrombosis Research|September 1, 1994
Coagulation inhibition capacities of low-molecular mass and unfractionated heparin, as determined by thrombin generationG Elgue, J Sanchez, N Egberg, et al.Thrombosis Research|June 1, 1991
Heparin cofactor II significance for the inhibition of thrombin at the injured vessel wallB Pasche, J Swedenborg, S Frebelius, et al.Thrombosis and Haemostasis|June 28, 1990
The use of a commercial ELISA for assay of thrombin-antithrombin complexes in purified systemsG Elgue, B Pasche, M Blombäck, et al.Bioconjugate Chemistry|September 1, 1996
Development and in vitro studies of epidermal growth factor-dextran conjugates for boron neutron capture therapyL Gedda, P Olsson, J Pontén, et al.Pageof 77